On December 9, 2025, Teleflex Inc announced two significant agreements to sell its Original Equipment Manufacturing and Development Services business for $1.5 billion and its Acute Care and Interventional Urology segment for $530 million, with expected completions in the second half of 2026. The proceeds will be used for share repurchases and debt repayment.